<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0209682.ref084" class="ref">
 <label class="label">84</label>
 <mixed-citation publication-type="journal" class="mixed-citation">
  <name class="name">
   <surname class="surname">Bernard</surname>
   <given-names class="given-names">MP</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Bancos</surname>
   <given-names class="given-names">S</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Sime</surname>
   <given-names class="given-names">PJ</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Phipps</surname>
   <given-names class="given-names">RP</given-names>
  </name>. 
  <article-title class="article-title">Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise</article-title>. 
  <source class="source">Current pharmaceutical design</source>. 
  <year class="year">2008</year>;
  <volume class="volume">14</volume>(
  <issue class="issue">21</issue>):
  <fpage class="fpage">2051</fpage>â€“
  <lpage class="lpage">2060</lpage>. 
  <?supplied-pmid 18691115?>
  <pub-id pub-id-type="pmid" class="pub-id">18691115</pub-id>
 </mixed-citation>
</ref>
